SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 240 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,564 | +141.0% | 56,739 | +162.8% | 0.02% | +166.7% |
| Q2 2023 | $649 | -63.8% | 21,594 | -56.3% | 0.01% | -72.7% |
| Q1 2023 | $1,792 | +60.7% | 49,464 | +58.1% | 0.02% | +37.5% |
| Q4 2022 | $1,115 | -99.9% | 31,281 | -40.5% | 0.02% | -15.8% |
| Q3 2022 | $1,780,000 | +420.5% | 52,598 | +344.2% | 0.02% | +375.0% |
| Q2 2022 | $342,000 | -85.4% | 11,841 | -85.3% | 0.00% | -71.4% |
| Q4 2021 | $2,349,000 | +312.1% | 80,576 | +277.0% | 0.01% | +366.7% |
| Q3 2021 | $570,000 | +68.1% | 21,374 | +49.7% | 0.00% | -70.0% |
| Q2 2020 | $339,000 | – | 14,282 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |